1-4 of 4
Eric Yvon, MS
Close
Sort by
Journal Articles

Exploiting Cytokine Secretion to Rapidly Produce Multivirus-Specific T Cells for Adoptive Immunotherapy

Yuriko Fujita, MD, Ann M. Leen, PhD, Jiali Sun, Yozo Nakazawa, MD, PhD, Eric Yvon, MS, Helen E. Heslop, MD, Malcolm K. Brenner, MD, PhD, FRCP, FRCPath, Cliona M. Rooney, PhD
Journal: Blood
Blood (2008) 112 (11): 4594.
https://doi.org/10.1182/blood.V112.11.4594.4594
Published: 2008
Journal Articles

Vaccination Strategies for Patients with B-CLL.

Fatma V Okur, MD, Eric Yvon, MS, Gianpietro Dotti, MD, George Carrum, MD, Helen E. Heslop, MD, Malcolm K Brenner, MD, PhD, Joseph C. Fratantoni, MD, Madhusudan V Peshwa, PhD, Linhong Li, PhD
Journal: Blood
Blood (2008) 112 (11): 2106.
https://doi.org/10.1182/blood.V112.11.2106.2106
Published: 2008
Journal Articles

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Joseph C. Fratantoni, MD, Linhong Li, PhD, Linda N. Liu, PhD, Madhusudan V. Peshwa, PhD, Malcolm Brenner, MD, PhD, Eric Yvon, MS, George Carrum, MD, Ettore Biagi, MD
Journal: Blood
Blood (2005) 106 (11): 450.
https://doi.org/10.1182/blood.V106.11.450.450
Published: 2005
Journal Articles

Molecular Transfer of Human CD40 and OX40 Ligands to Leukemic Human B-CLL Cells Extensively Expands Tumor-Reactive Cytotoxic T-Lymphocytes.

Ettore Biagi, MD, Giampietro Dotti, MD, Eric Yvon, MS, Raphael Rousseau, MD, Edward Lee, MD, Stephen Gotschalk, MD, PhD, Malcolm Brenner, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 951.
https://doi.org/10.1182/blood.V104.11.951.951
Published: 2004